Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21402713

Cancer Res. 2011 May 1 71 9 3317-27

Download in:

View as

General Info

PMID
21402713